Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000899243-20-019850

10% owner acquired 12,799,078 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Third Rock Ventures III, L.P. 10% owner 2020-07-20 Conversion +9,970,454 9,970,454 D: show line 1 in the form
Third Rock Ventures III, L.P. 10% owner 2020-07-20 Conversion +2,793,770 2,793,770 I: show line 2 in the form
Third Rock Ventures III, L.P. 10% owner 2020-07-20 Conversion +17,427 9,987,881 D: show line 3 in the form
Third Rock Ventures III, L.P. 10% owner 2020-07-20 Conversion +17,427 2,811,197 I: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Third Rock Ventures III, L.P. 10% owner 2020-07-20 Conversion · Series A Convertible Preferred Stock −35,404,286 0 D: show line 5 in the form
Third Rock Ventures III, L.P. 10% owner 2020-07-20 Conversion · Series A Convertible Preferred Stock −9,920,455 0 I: show line 6 in the form
Third Rock Ventures III, L.P. 10% owner 2020-07-20 Conversion · Series B Convertible Preferred Stock −61,881 0 D: show line 7 in the form
Third Rock Ventures III, L.P. 10% owner 2020-07-20 Conversion · Series B Convertible Preferred Stock −61,881 0 I: show line 8 in the form
Loading xslF345X03/doc4.xml…